Stereotaxis (STXS) Gross Margin (2010 - 2026)

Stereotaxis' (STXS) quarterly Gross Margin came in at 60.31% in Q1 2026, up 592.0% year-on-year from 8.72% in Q1 2025, and up 20.45% on a QoQ basis from 50.07% in Q4 2025.

Stereotaxis (STXS) Gross Margin (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has 17 years of Gross Margin data on file, last reported at 60.31% in Q1 2026.

  • On a quarterly basis, Gross Margin rose 592.0% year-over-year to 60.31% in Q1 2026; TTM through Mar 2026 was 53.86%, a 45.0% increase from a year earlier, with the FY2025 full-year figure at 52.73%, down 149.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 60.31%, up from 50.07% in the prior quarter.
  • Over the last five years, Gross Margin for STXS reached as high as 75.91% in Q2 2022 and fell as low as 44.57% in Q3 2024.
  • Historically, Gross Margin has averaged 58.08% across 5 years, with a median of 57.65% in 2024.
  • Across the five-year window, Gross Margin plunged 2263 bps in 2023 and surged 2031 bps in 2024, its largest moves.
  • Year by year, Gross Margin stood at 59.02% in 2022, then climbed by 2 bps to 59.98% in 2023, then fell by 15 bps to 50.73% in 2024, then declined by 1 bps to 50.07% in 2025, then rose by 20 bps to 60.31% in 2026.
  • Per Business Quant data, the three most recent Gross Margin figures were 60.31% in Q1 2026, 50.07% in Q4 2025, and 54.94% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn 56.80%
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn 67.78%
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn 45.69%
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn 25.04%
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn 62.25%
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn 37.74%
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn 68.00%
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn 54.66%
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn 70.82%
10 Stereotaxis 136.49 Mn 121.87 Mn 3.79 Mn 60.31%

Historic Data

Download Data
DateValue
Mar 31, 2026 60.31%
Dec 31, 2025 50.07%
Sep 30, 2025 54.94%
Jun 30, 2025 52.05%
Mar 31, 2025 54.39%
Dec 31, 2024 50.73%
Sep 30, 2024 44.57%
Jun 30, 2024 73.59%
Mar 31, 2024 57.65%
Dec 31, 2023 59.98%
Sep 30, 2023 52.05%
Jun 30, 2023 53.28%
Mar 31, 2023 59.19%
Dec 31, 2022 59.02%
Sep 30, 2022 59.64%
Jun 30, 2022 75.91%
Mar 31, 2022 69.97%
Dec 31, 2021 72.20%
Sep 30, 2021 51.99%
Jun 30, 2021 72.17%